News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,268 Results
Type
Article (5458)
Company Profile (22)
Press Release (153788)
Section
Business (41268)
Career Advice (66)
Deals (7637)
Drug Delivery (7)
Drug Development (25687)
Employer Resources (5)
FDA (4705)
Job Trends (3721)
News (80044)
Policy (8218)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (1)
Academia (581)
Allergies (16)
Alliances (10511)
ALS (27)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (18)
Approvals (4744)
Artificial intelligence (85)
Autoimmune disease (5)
Automation (7)
Bankruptcy (58)
Best Places to Work (3462)
Biosimilars (24)
Biotechnology (20)
Bladder cancer (31)
Brain cancer (8)
Breast cancer (123)
Cancer (828)
Cardiovascular disease (49)
Career advice (62)
CAR-T (27)
Cell therapy (102)
Cervical cancer (7)
Clinical research (21359)
Collaboration (302)
Compensation (157)
Complete response letters (2)
COVID-19 (1803)
CRISPR (11)
C-suite (62)
Cystic fibrosis (24)
Data (886)
Depression (13)
Diabetes (56)
Diagnostics (1983)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (28)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (15)
Earnings (19754)
Editorial (3)
Employer branding (1)
Employer resources (4)
Events (24788)
Executive appointments (261)
FDA (5162)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (255)
Gene editing (22)
Generative AI (4)
Gene therapy (85)
GLP-1 (105)
Government (1208)
Grass and pollen (1)
Guidances (16)
Healthcare (4387)
Huntington's disease (6)
IgA nephropathy (2)
Immunology and inflammation (15)
Indications (11)
Infectious disease (1865)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (28)
Interviews (6)
IPO (3435)
IRA (1)
Job creations (556)
Job search strategy (60)
Kidney cancer (6)
Layoffs (45)
Legal (1647)
Liver cancer (20)
Lung cancer (126)
Lymphoma (65)
Management (1)
Manufacturing (76)
MASH (22)
Medical device (2831)
Medtech (2831)
Mergers & acquisitions (4431)
Metabolic disorders (129)
Multiple sclerosis (14)
NASH (5)
Neurodegenerative disease (17)
Neuropsychiatric disorders (3)
Neuroscience (449)
NextGen: Class of 2025 (713)
Non-profit (773)
Northern California (766)
Now hiring (1)
Obesity (45)
Opinion (20)
Ovarian cancer (26)
Pain (29)
Pancreatic cancer (29)
Parkinson's disease (38)
Partnered (3)
Patents (60)
Patient recruitment (31)
Peanut (9)
People (10597)
Pharmaceutical (2)
Phase I (5891)
Phase II (9021)
Phase III (8165)
Pipeline (297)
Podcasts (2)
Policy (4)
Postmarket research (956)
Preclinical (2185)
Press Release (54)
Prostate cancer (41)
Psychedelics (2)
Radiopharmaceuticals (66)
Rare diseases (90)
Real estate (1099)
Recruiting (3)
Regulatory (6008)
Reports (10)
Research institute (670)
Resumes & cover letters (7)
Rett syndrome (3)
RNA editing (1)
RSV (12)
Schizophrenia (17)
Series A (45)
Series B (30)
Service/supplier (3)
Sickle cell disease (18)
Southern California (592)
Special edition (1)
Sponsored (3)
Startups (455)
State (1)
Supply chain (22)
The Weekly (2)
United States (8129)
Vaccines (310)
Venture capitalists (1)
Weight loss (13)
Women's health (9)
Date
Today (72)
Last 7 days (291)
Last 30 days (1366)
Last 365 days (12060)
2025 (2982)
2024 (10823)
2023 (10275)
2022 (14252)
2021 (15448)
2020 (15195)
2019 (9338)
2018 (6865)
2017 (6860)
2016 (6472)
2015 (7848)
2014 (5710)
2013 (4764)
2012 (5452)
2011 (5653)
2010 (5671)
Location
Africa (94)
Alabama (14)
Arizona (21)
Arkansas (3)
Asia (7738)
Australia (885)
California (1756)
Canada (606)
China (117)
Colorado (107)
Connecticut (135)
Delaware (85)
Europe (18521)
Florida (212)
Georgia (52)
Idaho (5)
Illinois (146)
India (9)
Indiana (63)
Iowa (4)
Japan (72)
Kansas (8)
Kentucky (4)
Maine (4)
Maryland (183)
Massachusetts (1402)
Michigan (32)
Minnesota (73)
Missouri (25)
Montana (2)
Nebraska (2)
Nevada (23)
New Hampshire (67)
New Jersey (1393)
New Mexico (20)
New York (709)
North Carolina (871)
North Dakota (8)
Northern California (766)
Ohio (43)
Oklahoma (2)
Oregon (13)
Pennsylvania (288)
Puerto Rico (1)
Rhode Island (7)
South America (220)
South Carolina (2)
South Dakota (1)
Southern California (592)
Tennessee (36)
Texas (298)
Utah (27)
Virginia (42)
Washington D.C. (12)
Washington State (162)
West Virginia (2)
Wisconsin (34)
159,268 Results for "qiagen n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
January 15, 2025
·
1 min read
QIAGEN N.V. to release results for Q1 2024 and hold webcast
QIAGEN N.V. announced plans to release results for the first quarter 2024.
April 9, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q3 2024 and hold webcast
October 10, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q4 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.
January 11, 2024
·
1 min read
Business
QIAGEN N.V. to release results for Q3 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter 2023.
October 9, 2023
·
1 min read
Business
QIAGEN N.V. to release results for Q2 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.
July 24, 2023
·
1 min read
Press Releases
QIAGEN delivers solid Q4 2024 growth ahead of outlook
February 5, 2025
·
7 min read
Press Releases
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
February 14, 2025
·
5 min read
Press Releases
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
March 6, 2025
·
6 min read
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
QIAGEN N.V. announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new approach for liquid biopsy.
April 3, 2024
·
8 min read
1 of 15,927
Next
